VOLTA, MATTIA
 Distribuzione geografica
Continente #
EU - Europa 134
NA - Nord America 90
AS - Asia 49
Totale 273
Nazione #
IT - Italia 108
US - Stati Uniti d'America 89
SG - Singapore 24
CN - Cina 12
VN - Vietnam 12
FR - Francia 5
NL - Olanda 5
ES - Italia 4
DE - Germania 3
FI - Finlandia 3
IE - Irlanda 2
CA - Canada 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
IN - India 1
LU - Lussemburgo 1
RU - Federazione Russa 1
Totale 273
Città #
Santa Clara 21
Singapore 20
Dong Ket 12
Boardman 11
Rome 9
Fairfield 8
Seattle 8
Milan 7
Ashburn 5
Houston 4
Barcelona 3
Beijing 3
Ogden 3
Padova 3
Selvazzano Dentro 3
Turin 3
Busto Arsizio 2
Dallas 2
Dublin 2
Helsinki 2
Naples 2
Nogaredo 2
Rimini 2
Amsterdam 1
Biancavilla 1
Brescia 1
Castelraimondo 1
Catania 1
Chiswick 1
Cordenons 1
Este 1
Florence 1
Grezzana 1
Lappeenranta 1
Las Vegas 1
Los Angeles 1
Luxembourg 1
Madrid 1
Medford 1
Portici 1
Princeton 1
Roxbury 1
San Diego 1
Toronto 1
Trieste 1
Vicenza 1
Wilmington 1
Woodbridge 1
Xingtai 1
Totale 163
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 146
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 64
Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release 21
Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats. New insights into the role of delta receptors in parkinsonism 11
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity 10
Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson's disease: a behavioral and neurochemical study in reserpinized mice 9
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-Cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4) 9
Stimulation of Delta Opioid Receptor and Blockade of Nociceptin/Orphanin FQ Receptor Synergistically Attenuate Parkinsonism 7
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 6
Totale 283
Categoria #
all - tutte 1.328
article - articoli 1.328
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 0 0 0 7 0 13
2021/202222 1 0 0 6 0 0 0 3 1 0 4 7
2022/202317 2 0 0 0 0 1 0 8 3 0 3 0
2023/2024123 1 1 14 20 13 9 11 15 10 4 14 11
2024/2025101 6 22 19 20 32 2 0 0 0 0 0 0
Totale 283